TR
Transgene S.A.
TRGNF · OTC
$1.00 +0.00% (+$0.00)
Market Cap 114.2M €
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
3 /100
Expensive P/S 17.97x
P/B 7.51x
P/E N/A
Growth
0 /100
Declining Rev. growth 38.28%
Book val. growth 16.80%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 439.56%
Net margin 534.72%
Op. margin 561.28%
Quality
3 /100
Poor ROIC 125.69%
ROA 80.55%
Asset turnover 0.15x
Debt
67 /100
Low Debt/Equity 0.68x
Current ratio 1.48x
Int. coverage -16.62x
Stability
46 /100
Moderate Beta 0.68x
Rev. volatility 178.09%
EPS volatility 30.20%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o TRGNF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Alessandro Riva
Employees
156
Headquarters
Illkirch-Graffenstaden
Prihajajoči dogodki
24 SEP.
Earnings
Upcoming earnings report